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Summary
The arduous task of rationally designing small molecule enzyme inhibitors is complicated by the
inherent flexibility of the protein scaffold. To gain insight into the changes in dynamics associated
with small molecule based inhibition, we have characterized, using NMR spectroscopy, E. coli
dihydrofolate reductase in complex with two drugs: methotrexate and trimethoprim. The complexes
allowed the intrinsic dynamic effects of drug binding to be revealed within the context of the “closed”
structural ensemble. Binding of both drugs results in an identical decoupling of global motion on the
micro- to millisecond timescale. Consistent with a change in overall dynamic character, the drugs’
perturbations to pico- to nanosecond backbone and side-chain methyl dynamics are also highly
similar. These data show that the inhibitors simultaneously modulate slow concerted switching and
fast motions at distal regions of DHFR, providing a dynamic link between the substrate binding site
and distal loop residues known to affect catalysis.
Introduction
Proteins adopt ensembles of conformations in solution. Although this is often demonstrated
with enzymes, the dynamic equilibria between structural substates in either catalytic or non-
catalytic proteins have a direct impact on substrate or ligand binding, catalysis, and product
release (Boehr et al., 2006; Careri et al., 1979; Eisenmesser et al., 2002; Frederick et al.,
2007; Karplus and McCammon, 2002; Lee et al., 2000; Watt et al., 2007; Zidek et al., 1999).
Understanding how protein dynamics influences small molecule binding and release should
therefore greatly enhance efficient rational drug design (Teague, 2003). Surprisingly, few
experimental studies have focused on the dynamical consequences of drug inhibition. Herein,
we detail a structural and multi-timescale dynamical study of Escherichia coli dihydrofolate
reductase bound to its cofactor NADPH and to either of the small molecule drugs methotrexate
(MTX) or trimethoprim (TMP). NMR spectroscopy is uniquely suited to study protein structure
and dynamics in solution with atomic resolution and was used extensively in this report.
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Dihydrofolate reductase (DHFR) is a classic drug target and one of the most comprehensively
studied enzymes (Schnell et al., 2004b). It catalyzes the NADPH-dependent reduction of
dihydrofolate to tetrahydrofolate. Tetrahydrofolate is required for the biosynthesis of DNA
bases and key amino acids. DHFR thus plays a vital role in cell proliferation, and is a popular
target for chemotherapeutic agents. MTX and TMP are established antifolates against DHFR,
sharing a common 2,4-diamino pyrimidine moiety (Figure 1A). MTX, the first successful anti-
cancer drug (2006; Huennekens, 1994), not only binds to human DHFR, but it also binds with
low nanomolar affinity to the E. coli enzyme (Sasso et al., 1994). TMP is an antibiotic that
specifically targets the bacterial enzyme, also binding with high affinity (Kd = 6 pM) (Sasso
et al., 1994). We sought to determine how binding of these different drugs impacts the motions
of this functionally dynamic enzyme.
During its catalytic cycle, E. coli DHFR switches between “closed” and “occluded”
conformations (Sawaya and Kraut, 1997). This global exchange is largely defined by the
conformation of the Met20 loop flanking the active site (Figure 1B). In the closed
conformation, the nicotinamide moiety of NADPH is buried within the active site. The Met20
loop packs against the cofactor, closing the active site to solvent. The closed conformation is
partially stabilized by hydrogen bond interactions between the Met20 loop and the F-G loop
(Figure 1B)(Sawaya and Kraut, 1997). Upon hydride transfer, DHFR undergoes a
conformational switch to the occluded conformation. The Met20 loop forms a short 310 helix,
projecting the side chain of M16 into the active site, thus occluding the cofactor binding pocket.
To form the occluded conformation, hydrogen bond interactions between the Met20 loop and
the F-G loop are broken, and new interactions with the residues on the G-H loop are formed
(Sawaya and Kraut, 1997). While the work of Wright and colleagues have focused on the
catalytic cycle and how dynamics are modulated by the conformation of the Met20 loop (Boehr
et al., 2006; McElheny et al., 2005; Osborne et al., 2001; Schnell et al., 2004a, b), less has been
reported on how inhibitors alter E. coli DHFR dynamics. In fact, even though the same (closed)
conformation is present before and after dihydrofolate or drug binding, there have been few
studies of the effect of ligand binding in the context of the closed state. Most studies have either
involved binding at the cofactor site or the study of major conformational change in the loops
flanking the active site of DHFR (for a review see (Schnell et al., 2004b)). The study of drug
binding within the closed state allows intrinsic drug binding effects to be separated from
subsequent conformational changes.
In this paper, we present the results of a comprehensive dynamical investigation of DHFR
inhibition brought about by small molecule drugs. Use of MTX and TMP ligands in this system
allows for NMR-monitored dynamics to report on both the sampling of minor semi-stable
conformations within the closed ensemble, as well as smaller, faster motions that may lead to
those conformational excursions. Experiments sensitive to micro- to millisecond (μs-ms)
conformational dynamics indicate localized regions of drug-bound DHFR experience slow
motion analogous to the reactive complex (vide infra). Moreover, MTX and TMP alter the
collective enzyme motions in exactly the same manner: residues lining the drugs retain their
μs-ms switching, whereas distal loops stop switching altogether. Thus, as a whole, the inhibited
protein is dynamically dysfunctional. Drug-bound DHFR appears to be on the brink of a global
transition, but its restricted loops prevent the transition from occurring, leaving a “half-
switching” enzyme. Changes in pico- to nanosecond (ps-ns) backbone amide and side-chain
methyl dynamics indicate drug binding is “felt” throughout the protein. These changes in fast
dynamics show structural connectivity to distal loops implicated in function and provide insight
into the possible linkage between fast fluctuations that may precede or contribute to slower
switching events. Our results are consistent with experimental and theoretical studies that
indicate long-range coupling between the active site and distal regions of DHFR (Hammes-
Schiffer and Benkovic, 2006; Ohmae et al., 1996; Pan et al., 2000).
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Predominance of the closed conformation in solution upon drug binding
Crystal structures exist for the holoenzyme (E:NADPH) and the MTX complex
(E:NADPH:MTX) (Sawaya and Kraut, 1997), but not for the TMP complex (E:NADPH:TMP).
Although the holoenzyme has been crystallized in both closed and occluded states as shown
in Figure 1B, recent solution NMR work shows it to be predominantly closed in solution
(Osborne et al., 2003). The MTX complex, considered a model for DHFR’s transition state, is
also found in the closed conformation (Matthews et al., 1977; Sawaya and Kraut, 1997). While
the TMP complex has been solved for L. casei DHFR (Polshakov et al., 2002), the structural
features of the corresponding E. coli complex were unclear. Thus, we sought to determine the
structural state of the TMP complex and detect any differences in structure between the three
complexes using NMR chemical shifts and residual dipolar couplings (RDCs).
DHFR amide chemical shift changes are exquisitely sensitive to ligand binding and to the active
site loop conformation (Osborne et al., 2003). Chemical shift changes in response to MTX and
TMP binding were found to be primarily proximal to drug, thus reporting on ligand binding,
with similar patterns for the two drugs (Figure 2A). If either ternary protein complex were to
undergo a closed-occluded conformational change, one would expect clusters of sizable
chemical shift changes in the Met20 (residues 9-23), F-G (residues 117-131), and G-H (residues
142-149) loops (Osborne et al., 2003). In particular, the chemical shift changes in key marker
residues 121 and 149 are 10% and 20%, respectively, of the expected amount for the occluded
conformation. Although the conformational change is not observed, we note that significant
drug-dependent chemical shift change is observed at one position in the F-G loop (119) in the
case of MTX (Figure 2A). While the analogous change is not recognized as statistically
significant in the TMP complex, an obvious deviation from baseline is observed. These data
indicate the ensemble conformations of the drug bound complexes are nearly identical to the
holoenzyme.
RDC data confirm structural homogeneity between the three complexes. The correlation of
RDCs for either drug complex is strikingly linear with respect to the holoenzyme, indicative
of no significant conformational change (Figure 2B). This was corroborated upon calculation
of “quality factors” (Cornilescu et al., 1998), Q. RDCs of either drug complex show good
agreement with the closed form, Q = 0.24-0.27, and poor agreement with the occluded form,
Q = 0.46-0.53 (Figure 2B). Overall, the chemical shift and RDC data indicate the three DHFR
complexes are in the closed conformation, and that any large-scale structural differences are
imperceptible. Minor changes in chemical shift are observed in the F-G loop, suggestive of
propagation of subtle changes in local conformation and/or dynamics.
Drug-induced decoupling of a μs-ms functional global switch
As DHFR moves through its catalytic cycle, it undergoes slow, μs-ms collective motions that
are dependent on substrate, product, and cofactor ligands (Boehr et al., 2006). To see how these
functional motions are modulated by drug binding, 15N CPMG relaxation dispersion
experiments (Loria et al., 1999b) were carried out on the three closed complexes. The
dispersion data for all complexes were fitted to the general equation for the two-site exchange
model to yield the exchange rate (kex = k1+k-1), the change in chemical shift (Δω), and
populations pa and pb (Palmer et al., 2001). The residues that show dispersion in addition to
representative dispersion curves are shown in Figure 3.
The holoenzyme was previously characterized at 281 K, with supportive data at 284 K (Boehr
et al., 2006). Our holoenzyme data at 284 K are in agreement, showing 23 sites that yield
significant R2 dispersion (data not shown). At 298 K, a total of 7 sites yielded dispersions
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indicative of slow switching, all within the substrate binding region (Figure 3A). Initial fits
indicate the rate of motion to be fast (2000-4000 s-1) relative to the lower temperature (Boehr
et al., 2006). While R2 dispersion can be extremely sensitive for detecting the sampling of
minor states, the accessible time window is relatively narrow; thus, the reduction of sites
showing significant dispersions at 298 K may be due to a modest increase in exchange rates
(Palmer et al., 2001). Upon inspection, at 298 K, residues such as G121, a marker for global
conformational exchange (McElheny et al., 2005; Osborne et al., 2001; Osborne et al., 2003),
indeed show slight R2 dispersion curvature as a result of μs motion (Figure 3). Model-free
analysis of R1, R2, and 15N-{1H} NOE data at 298 K provide an additional, independent
evaluation of μs-ms timescale motion within DHFR. As shown in Figure 4A, models that
account for motion on the μs-ms timescale (i.e., models 3 and 4 that use an Rex term) are
required to accurately fit these data for many residues in the holoenzyme, indicating widespread
presence of μs-ms conformational exchange. Both Met20 and F-G loop residues require usage
of Rex terms. Thus, at 298 K, the holoenzyme active site and loops appear to be involved in
functional conformational switching (Figures 3A, 4A; Tables S1-S2), as observed previously
(Boehr et al., 2006).
Binding of MTX and TMP to the holoenzyme at 298 K results in ~10 residues exhibiting R2
dispersion in these complexes (Figure 3B, Table S1). These sets of residues are nearly identical
(8, 9, 28, 29, 30, 31, 111, 112 in both), cluster around the substrate/drug binding site, and
exhibit similar switching. The global kex rates are indistinguishable at 430 ± 150 s-1 and 460
± 170 s-1 for MTX and TMP, respectively, with both excited state populations at 2%. Thus,
MTX and TMP binding result in the same collective slow motion in DHFR, albeit slower than
in the holoenzyme. To test whether fast microsecond motions are present but difficult to detect
at 298 K, R2 dispersion curves were collected for the MTX ternary complex at 284 K. In stark
contrast to the holoenzyme, only one residue (A8) exhibited significant R2 dispersion,
indicating that much of the dynamics of the ternary complex is indeed quenched by drug (Figure
3B). It is striking that binding either drug leads to complete loss of R2 dispersion in the F-G
and G-H loops, while retaining slow motions around the substrate binding site (Figure 3). At
298 K, considering all indicators of slow motion (i.e. from R2 dispersion and model-free
analysis), the holoenzyme shows 47 sites experiencing microsecond motion, and the MTX and
TMP complexes show 18 and 23 sites experiencing μs-ms motion, respectively (Tables S1-
S4).
It should be mentioned that the E:NADP+:folate complex has been used as a model for the
closed, reactive Michaelis complex (McElheny et al., 2005). In this complex, the substrate
binding and loop regions undergo conformational change, apparently in a concerted, global,
closed-occluded conformational exchange, characterized by kex = 477 s-1 (reported at 303.4
K), although the observed structural change is manifested primarily in the loops and not the
substrate binding pocket (Sawaya and Kraut, 1997). The calculated forward closed-to-occluded
rate of the E:NADP+:folate complex at 298 K is 11 s-1 (McElheny et al., 2005), which,
coincidentally, matches the product release rate (Boehr et al., 2006). From our drug complex
data, the forward ground-to-excited rates of the substrate binding residues (see above) in the
closed ternary drug complexes (at 298 K) are similarly calculated to be 7.4 ± 2.7 s-1 and 10.6
± 3.8 s-1 for MTX and TMP complexes, respectively. Because these sites show the same
forward rate as for the corresponding region in the also-closed E:NADP+:folate complex, this
suggests that drug binding initiates similar “micro-switching” in the substrate binding pocket
to that which occurs in the global closed-to-occluded transition. It has recently been proposed
that the closed-occluded conformational change is an intrinsic feature of the E. coli DHFR
structure (Schnell et al., 2004b). While it is not clear whether a true closed-to-occluded
transition is occurring in the holoenzyme (Boehr et al., 2006) or at least partially in the substrate
binding pockets of the closed drug complexes, it is evident that drug binding slows down
motion in the binding pocket and removes functional loop conformational changes.
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Taking these data together, we conclude that in these two drug complexes, a dynamic
decoupling occurs. The active site (substrate binding pocket) behaves as if the enzyme is poised
to undergo the global transition that it has evolved to make, but MTX and TMP manage to
dampen and slow the larger concerted motion, probably via formation of stable contacts with
the nicotinamide moiety or protein (Sawaya and Kraut, 1997). In effect, the enzyme is “in a
dynamic straightjacket” and the loops cannot perform conformational switching, even though
the active site is initiating μs-ms timescale switching events. Thus, the coupled and temporally
correlated active site and loop motions, which are present in every physiological complex
(Boehr et al., 2006), have been decoupled by binding either MTX or TMP. We propose that
filling the active site sends a signal through the enzyme to initiate conformational change, but
these complexes are locked in the closed conformation and therefore the signal becomes
ineffective, resulting in a dysfunctional, “half-switching” enzyme (Figures 3, 4A).
Consensus drug-binding effects on ps-ns motions: pre-transitional connectivity to distal
loops that regulate DHFR activity
To expand the timescale range of the effects that MTX and TMP binding have on DHFR
dynamics, 15N dipolar and methyl 2H quadrupolar relaxation experiments were carried out on
all three complexes to characterize backbone and side-chain ps-ns dynamics at 298 K. The
relaxation data were interpreted in terms of the Lipari-Szabo “model-free” formalism, in which
the squared generalized order parameter indicates the motional restriction of the backbone N-
H bond (S2) or, in the case of side-chain methyl groups, the methyl symmetry axis (S2 axis)
(Lipari and Szabo, 1982). The order parameter can range between 0 and 1, corresponding to
complete disorder and a fixed orientation in the molecular frame, respectively. Because the
observed μs-ms dynamics are between a highly populated ground state and a lowly populated
excited state, the relaxation rates have negligible contribution from the excited state and
therefore report on conformational fluctuations (i.e., dynamics) within the closed, ground state
of each complex. In principle, isolating motion within the ground state ensemble may allow
identification of key, pre-transitional, motions that facilitate larger, slower conformational
changes, thus potentially enabling study of both cause and effect (of a conformational change).
To the extent that MTX (or even TMP) mimics the closed transition state along the reaction
coordinate (Sawaya and Kraut, 1997), the fluctuations will correspond to motions promoting
conformational changes associated with reactivity (Agarwal et al., 2002).
Backbone Dynamics—Backbone amide order parameters (S2) were extracted from 15N
R1, R2, and 15N-{1H} NOE data collected at two fields. Model selection was carried out using
global anisotropic tumbling (see Experimental Procedures) and yielded quite different models
for the holoenzyme vs. ternary drug complexes (Figure 4A). Specifically, model 3 (S2, Rex)
was selected for a large number of residues in the holoenzyme, indicating widespread μs-ms
motion, in contrast with significantly fewer residues in the drug complexes (see discussion
above). In addition, model 5 (S2 f, S2 s, τs), as well as complex motions that did not fit well to
any model, was frequently required in the F-G loop of the holoenzyme, with few complex
motions detected in the ternary complexes. Thus, drug binding simplifies the motional
landscape of the holoenzyme over a wide timescale range.
The model-selected backbone order parameters were found to reflect consistent dynamic
changes upon binding MTX and TMP. Although overall backbone flexibility is similar for the
three complexes, clear changes in order parameters (ΔS2) emerge for specific residues in
response to binding (Figure 4B). These changes follow similar trends for the two drugs, with
r = 0.74 (see insert). Because of the high quality of these data, we set a criterion for consensus
changes in dynamics: residues that showed significant change in S2 (≥ 2x error), in the same
direction, upon binding either drug. These consensus residues are 33, 51, 73, 134, and 159
(Figures 4B, 6). In addition, the adenosine binding loop residues 67-69 are individually noisy
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but collectively show average rigidification of about 0.05 in response to drug binding. These
consensus changes in backbone dynamics impart high confidence in altered flexibility observed
at sites that extend far beyond the substrate binding site. Finally, though it does not respond to
TMP, the catalytically important and distal residue G121 (in the F-G loop) undergoes an
increase in flexibility (by 0.06) in response to MTX binding (Figure 4B), 15 Å away.
Side-chain dynamics—Side-chain methyl order parameters (S2 axis) are exquisitely
sensitive probes to dynamic changes as a result of ligand binding (Fuentes et al., 2004; Lee et
al., 2000) and complement the backbone dynamics by increasing coverage. As shown in Figure
5, methyl side chains are evenly distributed in both the catalytic and adenosine binding
subdomains of DHFR providing a uniform probe of dynamics. The changes in S2 axis indicate
DHFR methyl groups generally become more rigid on the ps-ns timescale (Figures 5, S4), and
the MTX- and TMP-induced changes are correlated (r = 0.65). As expected, residues making
contact with drug show the largest changes. Interestingly, residues 60-62 in the adenosine
binding domain display significant changes in S2 axis in both ternary drug complexes. Drug
binding rigidifies I60δ1 and L62δ2, whereas I61δ1 becomes more flexible (Figure S4). Although
these residues are outside the substrate binding pocket, they are conserved in DHFR, are
prominent in a statistical coupling analysis (SCA) based network, and may be involved in
promoting catalysis (Chen et al., 2007). Spatially, they also lie in-between the substrate binding
site and loop residues 67-69. The changes in S2 axis provide additional evidence that the bulk
of the adenosine binding subdomain is dynamically linked to the substrate binding pocket. Of
special note, the dynamics of M20ε is very different between MTX and TMP complexes (0.20
vs. 0.50, Figure S4), although the methyl resonance was overlapped in the holoenzyme. Thus,
the dynamics of M20 is clearly perturbed upon binding one or both drugs.
The significant changes in side-chain and backbone ps-ns order parameters are summarized in
Figure 6. It is clear that local perturbation by small molecules has far reaching dynamic
consequences in this enzyme on the ps-ns timescale. Drug binding induces ps-ns dynamics
changes in residues 50, 51, 60, 61, 62 and 73, which essentially form a pathway to the base of
the loop containing the perturbed G67 (Figure 6). Similarly, dynamics and subtle chemical
shift changes are observed in the F-G loop, in particular, upon MTX binding. These findings
complement reports that demonstrate distal regions of DHFR to be linked to catalysis: mutation
of either G121 (F-G loop) or G67 (adenosine binding loop) have significant effects on kcat/
KM (Cameron and Benkovic, 1997;Gekko et al., 1994;Ohmae et al., 1996). Furthermore, G121
and G67 have been shown to be thermodynamically coupled with each other with respect to
kcat (Ohmae et al., 1998), despite their physical separation by 28 Å; and theoretical studies
suggest these residues are correlated to the active site (Agarwal et al., 2002;Pan et al.,
2000;Radkiewicz and Brooks, 2000). Our experimental data demonstrate a direct dynamic
connectivity, within the confines of the closed ensemble, between the active site and functional
distal regions in DHFR. This supports the idea that dynamics provides a mechanism for
propagating functional change observed upon mutation or ligand binding. Indeed, previous
NMR studies have shown that changes in ps-ns side-chain dynamics can reveal propagation
pathways linking distal sites (Clarkson and Lee, 2004;Fuentes et al., 2004), and in some cases,
linking distal functional sites (Igumenova et al., 2005;Namanja et al., 2007).
It is important to emphasize a key difference between the ps-ns dynamics comparison made
here and in previous studies (Osborne et al., 2001; Schnell et al., 2004a). In those studies,
dynamics changed in response to a change in the Met20 loop conformation. By contrast, here,
alterations in ps-ns dynamics is a direct result of ligand binding in the absence of
conformational change. Because the binding of antifolates such as MTX and TMP appears to
be the only way to study substrate binding effects (by NMR) without inducing a net
conformational change, such small molecules can be important tools for isolating pure dynamic
changes within the closed state, and potentially for capturing motions that trigger – or quench,
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depending on how one perceives the reference state – larger, slower dynamic events. From our
data, we can speculate that because the ps-ns motions of G121 are sensitive to ligand occupancy
in the context of the closed state, these results are consistent with G121, and perhaps its nearest
neighbors, participating in rapid, pre-transitional, initiating movements to the occluded
conformation (Chen et al., 2007; Radkiewicz and Brooks, 2000).
Sensitivity of closed conformational dynamics to ligand structure
Depending on ligand occupancy in its two binding sites, DHFR undergoes different μs-ms
switching dynamics (Boehr et al., 2006). The data here show that the high-affinity drugs MTX
and TMP cause novel “half-switching” behavior on the μs-ms timescale, with additional
perturbations to ps-ns fluctuations. While the Met20 loop conformation is clearly an important
factor in regulating DHFR dynamics (Osborne et al., 2001; Schnell et al., 2004a), we propose
that, even with a fixed Met20 loop conformation, motions across a wide range of timescales
can be regulated by the specific nature of ligands bound. Occupation of the active site by small
ligands of different shapes and physical characteristics places differential stresses on the
enzyme, resulting in differential thermal fluctuations that propagate through the structure. In
this view, enzymes, through evolution, develop sensitivities to ligand properties from which
mechanisms for organizing and building such fluctuations into useful work can arise. The
collective results on DHFR dynamics support the notion of a so-called “allosteric wiring
network” that connects distal regions of the protein (Chen et al., 2007; Hammes-Schiffer and
Benkovic, 2006). It has been suggested that coordinated motions within the network are
responsible for controlling the large conformational transition (Chen et al., 2007) and the
chemical step of catalysis (Agarwal et al., 2002) in DHFR. Binding MTX or TMP may disrupt
these motions and reduce connectivity within the network, preventing the transition from
occurring.
Concluding remarks
In this report, we have presented a dynamic survey of DHFR with reduced cofactor in the
presence and absence of two potent inhibitory drugs, methotrexate (MTX) and trimethoprim
(TMP). Binding either drug results in essentially identical behavior: quenched μs-ms
conformational exchange in the Met20, F-G, and G-H loops, and slowed substrate binding site
μs-ms dynamics. MTX and TMP partially suppress the global conformational switching that
is found in every physiological complex (Boehr et al., 2006); however, this suppression takes
place within the closed conformational ensemble. On the ps-ns timescale, both backbone
amides and methyl side chains show sparse, yet largely consistent changes in their dynamics
as a result of drug binding. The changes in these fast motions show that, despite a lack of overall
conformational change, changes propagate to the distal F-G and adenosine binding loops that
contain residues implicated in DHFR function. The emergent picture is that upon binding high-
affinity drug, the enzyme is on the brink of a structural transition, yet trapped in the closed
conformation. It is left undergoing slow, correlated switching in the substrate binding site.
Because the affected loop structures are primarily not in contact with drug, it is reasonable to




DHFR was expressed in M9 minimal media supplemented with combinations of 15NH4Cl, D-
glucose (U-13C6-99%), and 2H2O. The cells were harvested by centrifugation and suspended
in lysis buffer (20 mM sodium phosphate, 50 mM sodium chloride, 1 mM EDTA, and 1 mM
DTT pH 6.8). DHFR was purified using methods similar to those previously described
(Rajagopalan et al., 2002). Cell lysate was loaded onto a MTX affinity column (Sigma). The
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column was washed with lysis buffer containing 750 mM NaCl, and protein was eluted with
buffer containing 20 mM sodium borate, 750 mM NaCl, 1 mM EDTA, 1 mM DTT, 5 mM
folate pH 9.0. The eluent was passed over a G-50 gel filtration column (GE Biosciences)
equilibrated with KPE (50 mM potassium phosphate, 150 mM KCl, 1 mM EDTA, and 1mM
DTT pH 6.8). Any remaining folate was removed by dialysis against KPE containing 5 M
deionized urea. Finally, DHFR was passed over a G-50 column equilibrated with NMR Buffer
(70 mM HEPES, 20 mM KCl, 1 mM EDTA, and 1 mM DTT pH 7.6). Pure DHFR was
concentrated, lyophilized, and stored at 4 °C. Sample purity was estimated by SDS-PAGE and
verified by ESI-MS to be greater than 97%.
NMR Samples
NMR experiments were performed on 1 mM DHFR in NMR Buffer containing 15 mM
NADPH, 10 mM glucose-6-phosphate and 10 U glucose-6-phosphate dehydrogenase and,
when applicable, 3-5 mM MTX or 2-3 mM TMP. The protein was placed in amber NMR tubes
and flame sealed under argon.
NMR Spectroscopy
All NMR experiments were conducted at 298 or 284 K on Varian spectrometers equipped with
room-temperature (500 and 600 MHz) or cryogenic probes (700 MHz). Backbone and side-
chain resonances were assigned using standard triple resonance methods. NMR data were
processed with NMRPipe (Delaglio et al., 1995) and visualized with NMRDraw and
NMRView (Johnson and Blevins, 1994). Combined chemical shifts for the purposes of
chemical shift mapping were calculated using the Euclidean distance (Schumann et al.,
2007). Significant changes in combined chemical shift were identified using the boxplot
function in Matlab R2006b (Mathworks).
Relaxation dispersion measurements were performed at 500, 600, and 700 MHz using
relaxation-compensated CPMG experiments (Loria et al., 1999a). The total CPMG period was
40 ms in all experiments. The effective field strength was modulated by changing the delay
time, τ. Sixteen HSQC-type spectra composed of 13 τ values between 0.556 and 10 ms, two
duplicates, and a reference experiment were collected interleaved. Peak intensities were
extracted using the NMRDraw module nlinLS. Effective R2 rates were calculated as described
(Mulder et al., 2001). Highly deuterated DHFR was used for measuring E:NADPH and
E:NADPH:MTX relaxation dispersion while protonated DHFR was used for E:NADPH:TMP.
Standard backbone relaxation experiments were used to collect the R1, R2, and {1H}-15N NOE
data at 500 and 600 MHz (Farrow et al., 1994). Side-chain 2H Dz and Dy relaxation experiments
(Millet et al., 2002) were collected using multi-coherence relaxation pulse sequences, similar
to previously described (Fuentes et al., 2004).
Relaxation Analysis
Motions occurring on the μs-ms timescale were characterized assuming a two-state model.
Only residues for which R2,eff changed >2 s-1 over the series of time points were considered
for further analysis. The data were best-fitted to a model assuming no exchange (R2=R2 o) and
a simple two state model. An F-test (alpha critical = 0.01) was used to identify residues with
statistically significant exchange. To determine exchange kinetics, effective R2 rates as a
function of τ-1 at two fields were fit simultaneously to the Carver-Richards equation (Palmer
et al., 2001) using the in-house program exrate2.0 (by R.V.M). The errors in fitted parameters
were estimated using Monte Carlo simulation. Relaxation dispersion data often report on a
global exchange process and can be fitted using shared kex and pa values. To identify these
residues, we followed the procedure outlined by Kay and coworkers (Mulder et al., 2001). As
previously described, residues 129-134 and 155-159 in E. coli DHFR report on ligand
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independent exchange (Boehr et al., 2006). These residues were not included in any global fit
and were not considered in this study.
Motions on the ps-ns timescale were characterized using the model-free formalism (Lipari and
Szabo, 1982). Using the strategy outlined by Dellwo and Wand (Dellwo and Wand, 1989) the
isotropic rotational correlation times for the binary and ternary complexes were determined to
be 11.2 and 10.5 ns/rad, respectively. While the ternary correlation times are shorter than the
binary, the effect is small and could be explained by deviation from isotropic tumbling, a change
in hydration patterns around the active site, or a small degree of non-specific aggregation in
the binary complex. Rotational diffusion anisotropy was calculated via the local Di method
(Lee et al., 1997) using the in-house program qfit and the PDB file 1rx3. The values of D∥/
D┴ for the E:NADPH, E:NADPH:MTX, and E:NADPH:TMP complexes are 1.15, 1.18, and
1.14, respectively. Rotational anisotropy has been shown to have a large impact on backbone
model selection and was used in the subsequent analyses (Osborne and Wright, 2001).
Backbone relaxation rates were fitted to the five “model-free” models using the in-house
program relxn2.2 (Clarkson et al., 2006; Lee et al., 1999). The values used for the effective N-
H bond distance and the 15N chemical shift anisotropy were 1.02 Å and -170 ppm, respectively.
Akaike’s information criterion was used to select the model that best describes the motion
(d’Auvergne and Gooley, 2003). Side-chain methyl dynamics parameters were carried out as
described previously (Fuentes et al., 2004). The quadrupolar coupling constant was set to 165
kHz (Muhandiram et al., 1995).
Residual Dipolar Coupling
DHFR was partially aligned using a 6 mm stretched gel alignment kit (6% acrylamide) (Chou
et al., 2001). Cross-peak position of isotropic and anisotropic IPAP-HSQC spectra were
adjusted and fitted using the ipap.tcl and nlinLS modules provided in NMRPipe. The 1DHN
value was calculated by subtracting the measured coupling in the isotropic experiment from
the anisotropic experiment. The PDB file 1RX3 (closed) and 1RX5 (occluded) were used to
calculate Q-factors (Cornilescu et al., 1998). The data were analyzed using the program
REDCAT (Valafar and Prestegard, 2004).
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The structure of DHFR, its inhibitors, and substrate. A) The chemical structures of
trimethoprim, methotrexate, and dihydrofolate. B) DHFR transitions between the closed (red;
PDB 1rx3) and occluded (blue; PDB 1rx5) Met20 loop conformations. This transition involves
breaking hydrogen bonds with the F-G loop and creating interactions with the G-H loop
illustrated by the red (closed) and blue (occluded) dashed lines. Regions of the DHFR structure
that do not undergo significant conformational change are rendered in grey. Methotrexate is
shown in magenta and NADPH in orange. NADPH is illustrated occupying the active site,
which can only occur in the “closed” conformation.
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Conformational effects of DHFR due to drug binding. A) The combined change in 1H
and 15N chemical shifts, relative to holoenzyme, are plotted for the MTX (red) and TMP (black)
complexes. Significant changes are indicated by filled circles. B) Linear correlation
between 1H-15N RDC values for the drug complexes and the holoenzyme suggest they are in
the same conformation. Q-factors indicate that RDCs agree closely with the closed
conformation. PDB IDs 1rx3 and 1rx5 were used for the closed and occluded conformations,
respectively.
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R2 relaxation dispersion of DHFR, holo and bound to drugs. A) Relaxation dispersion of the
holoenzyme was recorded at two temperatures, 284 K and 298 K. Due to the fast exchange
rates, only 7 residues show significant dispersions at the higher temperature (orange spheres).
At 284 K, the same residues were observed (orange spheres) in addition to the residues
indicated by red spheres. The R2 dispersion profiles for G121 at 298 K (orange) and 284 K
(red) are plotted. B) Residues that exhibit significant R2 dispersion in MTX and TMP
complexes at 298 K only (blue and green spheres, respectively). In the case of the MTX
complex, A8 (orange sphere) also exhibited dispersion at 284 K. Conformational exchange is
localized to the active site in both complexes. The fitted R2 dispersion profiles for active site
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residue F31 are shown (blue and green). In stark contrast to the holoenzyme, drug binding
quenches exchange in the functional loops of DHFR, as indicated by the flat dispersion profiles
(black lines) of G121 (black spheres).
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The “model-free” dynamic response of DHFR to drug binding. A) Model selection results for
E:NADPH, E:NADPH:MTX, and E:NADPH:TMP. Structures are colored as follows (models
1-5): S2 only in blue; S2 and τe in cyan; S2 and Rex in yellow; S2, Rex, and τe in green; and S2 f,
S2 s, and τe in red. Residues that did not fit to a model are orange, and residues that could not
be fit due to spectral overlap are gray. B) The change in backbone order parameter due to MTX
(red) and TMP (black) binding to the holoenzyme. Residues that experience consensus
significant change are indicated by filled circles. G121 (blue fill) shows a dynamic response
in the MTX complex. Residues 67-69 (green stippling) exhibit a consistent, slight increase in
rigidity. The inset shows the correlation in the dynamic responses of DHFR (relative to
holoenzyme) to binding both drugs.
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Distribution of methyl bearing side chains in DHFR. Methyl sites within DHFR are represented
by the colored spheres. Residues that show significant change in order parameter (> 2x error)
as a result of binding A) MTX or B) TMP to the holoenzyme are shown in red. Residues that
do not change are represented by green spheres. Methyl sites that were not comparable due to
spectral overlap in the drug bound and/or holo enzyme are colored gray. The ligands MTX,
TMP, and NADPH are shown in magenta, cyan, and yellow, respectively.
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Summary of ps-ns dynamic changes. The dynamic response as a result of binding MTX or
TMP are illustrated in A) and B), respectively. Residues with significant change in backbone
amide (blue) and side-chain methyl (red) order parameter (complex – E:NADPH) are mapped
onto the DHFR structure. Residues 67-69 are highlighted in green. The ligands MTX, TMP,
and NADPH are shown in magenta, cyan, and yellow, respectively.
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